SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kosan BioSciences -- KOSN -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (887)2/29/2008 1:34:37 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 933
 
Actually, I was serious. With composition of matter (from your notes of the CC), I should have said "relative" weakness.

So company "F" (for "Formulation King) would have three shots on goal, instead of one (or two/two, etc.).

Anyway, a few more grunts and you'll be up 10% in a couple of days.

:-)



To: tuck who wrote (887)2/29/2008 1:55:21 PM
From: rkrw  Respond to of 933
 
I can tell you the synta ceo has been talking up their hsp90 inhibitor as (throw in your favorite hyperbole here).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News